Selassie J. Ogyaadu

Hypoglycemia in Prospective Multi-Center Study of Pregnancies with Pre-existing Type 1 Diabetes on Sensor Augmented Pump Therapy: The LOIS-P Study.

Mei Mei Church, Shelly K McCrady-Spitzer, Byron H. Smith, 2022, Diabetes technology & therapeutics.

Feasibility of Closed-Loop Insulin Delivery with a Pregnancy Specific Zone Model Predictive Control Algorithm.

Mei Mei Church, Shelly K McCrady-Spitzer, E. Dassau, 2022, Diabetes technology & therapeutics.

Pilot Study for Use of Intermittently Scanned Continuous Glucose Monitoring in Women with Gestational Diabetes

E. Nosova, C. Levy, Camilla M. Levister, 2022, Journal of diabetes science and technology.

Assessing Glycemic Control Using CGM for Women with Diabetes in Pregnancy

C. Levy, Grenye O’Malley, Selassie J. Ogyaadu, 2021, Current Diabetes Reports.

Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study.

M. Breton, S. Anderson, B. Buckingham, 2021, Diabetes care.

Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop (iDCL) Trial.

Mei Mei Church, Shelly K McCrady-Spitzer, C. Cobelli, 2020, Diabetes technology & therapeutics.

RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes

J. Penninger, N. G. Kondegowda, R. Vasavada, 2023, Science advances.